Nontranscriptional regulation of cardiac repolarization currents by testosterone

Circulation. 2005 Sep 20;112(12):1701-10. doi: 10.1161/CIRCULATIONAHA.104.523217. Epub 2005 Sep 12.

Abstract

Background: Women have longer QTc intervals than men and are at greater risk for arrhythmias associated with long QTc intervals, such as drug-induced torsade de pointes. Recent clinical and experimental data suggest an important role of testosterone in sex-related differences in ventricular repolarization. However, studies on effects of testosterone on ionic currents in cardiac myocytes are limited.

Methods and results: We examined effects of testosterone on action potential duration (APD) and membrane currents in isolated guinea pig ventricular myocytes using patch-clamp techniques. Testosterone rapidly shortened APD, with an EC50 of 2.1 to 8.7 nmol/L, which is within the limits of physiological testosterone levels in men. APD shortening by testosterone was mainly due to enhancement of slowly activating delayed rectifier K+ currents (IKs) and suppression of L-type Ca2+ currents (I(Ca,L)), because testosterone failed to shorten APD in the presence of an IKs inhibitor, chromanol 293B, and an I(Ca,L) inhibitor, nisoldipine. A nitric oxide (NO) scavenger and an inhibitor of NO synthase 3 (NOS3) reversed the effects of testosterone on APD, which suggests that NO released from NOS3 is responsible for the electrophysiological effects of testosterone. Electrophysiological effects of testosterone were reversed by a blocker of testosterone receptors, a c-Src inhibitor, a phosphatidylinositol 3-kinase inhibitor, and an Akt inhibitor. Immunoblot analysis revealed that testosterone induced phosphorylation of Akt and NOS3.

Conclusions: The nontranscriptional regulation of IKs and I(Ca,L) by testosterone is a novel regulatory mechanism of cardiac repolarization that can potentially contribute to the control of QTc intervals by androgen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects*
  • Androgen Antagonists / pharmacology
  • Animals
  • Electrophysiology / methods
  • Female
  • Guinea Pigs
  • Heart Ventricles / drug effects
  • Imidazolidines / pharmacology
  • In Vitro Techniques
  • Male
  • Membrane Potentials / drug effects
  • Models, Animal
  • Muscle Cells / drug effects
  • Muscle Cells / physiology*
  • Patch-Clamp Techniques
  • Testosterone / pharmacology*
  • Ventricular Function*

Substances

  • Androgen Antagonists
  • Imidazolidines
  • Testosterone
  • nilutamide